U.S. flag

An official website of the United States government

NM_005343.4(HRAS):c.191_217dup (p.Met72_Arg73insHisSerAlaMetArgAspGlnTyrMet) AND not provided

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Jan 17, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002254473.2

Allele description [Variation Report for NM_005343.4(HRAS):c.191_217dup (p.Met72_Arg73insHisSerAlaMetArgAspGlnTyrMet)]

NM_005343.4(HRAS):c.191_217dup (p.Met72_Arg73insHisSerAlaMetArgAspGlnTyrMet)

Genes:
HRAS:HRas proto-oncogene, GTPase [Gene - OMIM - HGNC]
LRRC56:leucine rich repeat containing 56 [Gene - OMIM - HGNC]
Variant type:
Duplication
Cytogenetic location:
11p15.5
Genomic location:
Preferred name:
NM_005343.4(HRAS):c.191_217dup (p.Met72_Arg73insHisSerAlaMetArgAspGlnTyrMet)
HGVS:
  • NC_000011.10:g.533839_533865dup
  • NG_007666.1:g.6686_6712dup
  • NM_001130442.3:c.191_217dup
  • NM_001318054.2:c.-129_-103dup
  • NM_005343.4:c.191_217dupMANE SELECT
  • NM_176795.5:c.191_217dup
  • NP_001123914.1:p.Met72_Arg73insHisSerAlaMetArgAspGlnTyrMet
  • NP_005334.1:p.Met72_Arg73insHisSerAlaMetArgAspGlnTyrMet
  • NP_789765.1:p.Met72_Arg73insHisSerAlaMetArgAspGlnTyrMet
  • LRG_506t1:c.191_217dup
  • LRG_506:g.6686_6712dup
  • LRG_506p1:p.Met72_Arg73insHisSerAlaMetArgAspGlnTyrMet
  • NC_000011.9:g.533839_533865dup
  • NM_176795.3:c.191_217dup27
Links:
dbSNP: rs2133990580
NCBI 1000 Genomes Browser:
rs2133990580
Molecular consequence:
  • NM_001318054.2:c.-129_-103dup - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001130442.3:c.191_217dup - inframe_insertion - [Sequence Ontology: SO:0001821]
  • NM_005343.4:c.191_217dup - inframe_insertion - [Sequence Ontology: SO:0001821]
  • NM_176795.5:c.191_217dup - inframe_insertion - [Sequence Ontology: SO:0001821]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002525672Seattle Children's Hospital Molecular Genetics Laboratory, Seattle Children's Hospital
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Jan 17, 2022)
somaticclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedsomaticyesnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Seattle Children's Hospital Molecular Genetics Laboratory, Seattle Children's Hospital, SCV002525672.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

A likely pathogenic variant was identified in exon 3 of HRAS (NM_005343.2:c.191_217dup27, p.Met72_Arg73insHisSerAlaMetArgAspGlnTyrMet). This variant was detected in 1.2% of reads, consistent with somatic origin. This variant is absent from the medical literature and the general population (gnomAD v2.1.1) The duplication of 27 base pairs causes an in-frame insertion of nine amino acids in the HRAS switch II domain, a region critical for binding regulator and effector proteins (PMID: 11701921). Although the c.191_217dup27 variant has not been previously reported, in-frame insertions and duplications within the switch II domain have been reported in individuals with arteriovenous malformations (PMID: 31637524) and RASopathies (PMID: 31160609, PMID: 23335589). In addition, functional analyses of similar in-frame insertions and duplications in the HRAS switch II domain have demonstrated that these variants lead to increased RAS signaling (PMID: 31160609, PMID: 23335589)

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1somaticyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Dec 24, 2023